ITP and TTP: interpreting evidence in light of patient values
摘要
In this issue of Blood, data presented by Zhou et al and Lim et al on the use of rituximab (RTX) to treat immune thrombocytopenia (ITP) and thrombotic thrombocytopenic purpura (TTP), respectively, illuminate the importance of considering patient values and preferences in the interpretation of clinical evidence.
引用本文（GB/T 7714）
Adam Cuker. ITP and TTP: interpreting evidence in light of patient values[J]. Blood, 2015.
引文网络
本站仅收录题录与摘要供学习参考，全文版权归属出版方；如有侵权请联系我们删除。